Megakaryocyte polyploidization is associated with decreased expression of polo-like kinase (PLK)

M Yagi1, G J Roth

  • 1Research, Seattle Division, Veterans Affairs Puget Sound Health Care System, WA 98108, USA. myagi@u.washington.edu

Abstract

Insights

Polo-like kinase 1 (PLK-1) is crucial for megakaryocyte (MK) polyploidization. Lower PLK-1 levels in polyploid MK suggest its role in regulating DNA replication without cell division during thrombopoiesis.

Area of Science:

  • Cell Biology
  • Hematology
  • Molecular Biology

Background:

  • Megakaryocytes (MK) differentiate through polyploidization, involving DNA replication without cell division.
  • Mature MK can reach high DNA content (up to 128N), impacting platelet production.
  • Understanding MK polyploidization mechanisms is key to controlling cell division and thrombopoiesis.

Purpose of the Study:

  • To investigate the expression of mitosis-related proteins in cultured mouse MK.
  • To determine the effect of protein expression on MK polyploidization.

Main Methods:

  • Western blot and immunofluorescence for cell cycle protein analysis in MK.
  • Flow cytometry to separate and analyze polyploidizing MK populations by DNA content.
  • Retroviral transduction to introduce mouse polo-like kinase 1 (PLK-1) into MK.

Main Results:

  • Polyploid MK showed reduced levels of p55CDC and PLK-1.
  • PLK-1 expression was absent in polyploid MK, unlike other cell cycle proteins.
  • Forced PLK-1 expression during MK differentiation led to decreased polyploidization.

Conclusions:

  • Polo-like kinase 1 (PLK-1) is identified as a significant regulator of polyploidization in differentiating MK.
  • The findings suggest PLK-1's role in controlling DNA replication and cell division during megakaryopoiesis.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...